Sensus Healthcare, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.7M | $6.6M | $485.0K | $24.2M | $4.1M | $-6.8M | $-1.7M | $-2.0M |
| Depreciation & Amortization | $400.0K | $200.0K | $275.0K | $315.0K | $613.0K | $722.0K | $545.7K | $658.3K |
| Depreciation | $386.0K | $239.0K | $200.0K | $219.0K | $509.0K | $613.0K | $449.0K | $562.0K |
| Amortization | — | — | — | — | $104.0K | $108.0K | $96.0K | $96.0K |
| Stock-Based Compensation | $295.0K | $323.0K | $328.0K | $187.0K | $415.0K | $386.0K | $620.9K | $982.6K |
| Net Cash from Operating Activities | $528.0K | $-831.0K | $-2.1M | $-1.4M | $-286.0K | $-434.0K | $-2.1M | $-8.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $196.0K | $276.0K | $229.0K | $159.0K | $128.0K | $359.0K | $400.6K | $854.8K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-196.0K | $-276.0K | $-187.0K | $14.8M | $129.0K | $7.0M | $-4.9M | $-2.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $300.0K | — | $27.0K | $3.0M | — | — | — | — |
| Net Cash from Financing Activities | $-305.0K | $15.0K | $-40.0K | $-2.4M | $-231.0K | $211.0K | $2.6M | $13.6M |
| Net Change in Cash | — | — | — | — | — | — | $-4.4M | $2.4M |
| Free Cash Flow | $332.0K | $-1.1M | $-2.4M | $-1.6M | $-414.0K | $-793.0K | $-2.5M | $-9.4M |